| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.77 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |